发明名称 HUMAN-G-PROTEIN RECEPTOR
摘要 The present invention relates to novel identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the G-protein coupled receptor family, referred to as IGS1-family. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and transgenic animals where the IGS1-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals). The invention further relates to a method for screening compounds capable to act as an agonist or an antagonist of said G-protein coupled receptor family IGS1 and the use of IGS1 polypeptides and polynucleotides and agonists or antagonists to the IGS1 receptor family in the treatment of psychiatric and CNS disorders.
申请公布号 IL146151(D0) 申请公布日期 2002.07.25
申请号 IL20000146151 申请日期 2000.07.17
申请人 SOLVAY PHARMACEUTICALS B.V. 发明人
分类号 A01K67/027;A61K31/7088;A61K38/00;A61K38/17;A61K45/00;A61K48/00;A61P1/04;A61P1/08;A61P1/12;A61P1/14;A61P3/04;A61P3/06;A61P3/10;A61P7/02;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/10;A61P13/12;A61P19/02;A61P19/10;A61P25/00;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P31/04;A61P31/10;A61P31/12;A61P31/18;A61P33/02;A61P35/00;A61P37/00;A61P37/08;C07K14/705;C07K14/72;C07K16/28;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09;C12N15/81;C12N15/85;C12P21/00;C12P21/02;C12Q1/02;C12Q1/68;G01N33/15;G01N33/50;G01N33/53;G01N33/566 主分类号 A01K67/027
代理机构 代理人
主权项
地址